Evidence map›Paper›PMID 21561740›Full record

Trial reportSchizophrenia research2011

Longitudinal consent-related abilities among research participants with schizophrenia: results from the CATIE study.

T Scott Stroup, Paul S Appelbaum, Hongbin Gu, Spencer Hays, Marvin S Swartz, Richard S E Keefe, Scott Y Kim, Theo C Manschreck, Roger A Boshes, Joseph P McEvoy and 1 more

Abstract readClinical TrialMulticenter Study
In one paragraph

Trial report in Schizophrenia research, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Ziprasidone versus other atypical antipsychotics for schizophrenia.The Cochrane database of systematic reviews · 2009
    Pooled it
  3. Article
  4. Increasing participation of people with thought disorder in clinical research.European psychiatry : the journal of the Association of European Psychiatrists · 2026
    Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Changes in capacity to consent over time in patients involved in psychiatric research.The British journal of psychiatry : the journal of mental science · 2013
    Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

T Scott StroupDepartment of Psychiatry, Columbia University College of Physicians and Surgeons, 1051 Riverside Drive, New York, NY 10032, United States. stroups@pi.cpmc.columbia.edu
Paul S Appelbaum
Hongbin Gu
Spencer Hays
Marvin S Swartz
Richard S E Keefe
Scott Y Kim
Theo C Manschreck
Roger A Boshes
Joseph P McEvoy
Jeffrey A Lieberman

Funding

PUBLIC EDUCATION CAMPAIGN ON DEPRESSION DARTN01MH090001 · NIMH · UNIVERSITY OF NORTH CAROLINA CHAPEL HILL · 1989 to 2003
$10.4M
Addressing Challenges in Schizophrenia ResearchK23MH067002 · NIMH · UNIV OF NORTH CAROLINA CHAPEL HILL · PI STROUP, THOMAS SCOTT · 2003 to 2007
$858k
NIMH NIH HHS 1K23MH67002-01A1NIMH NIH HHS K23 MH067002NIMH NIH HHS N01 MH090001
6 · The paper itself

Abstract

objectiveResearch participants must have adequate consent-related abilities to provide informed consent at the time of study enrollment. We sought to determine if research participants with schizophrenia maintain adequate consent-related abilities during a longitudinal study. If participants lose abilities during a trial they may not be able to judge and protect their interests. If reduced abilities are common or can be predicted, special protections can be targeted appropriately.

methodWe examined longitudinal consent-related abilities of participants in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia study using the MacArthur Competence Assessment Tool-Clinical Research (MacCAT-CR) at protocol-specified times over 18 months.

resultsOf 1158 research participants in this analysis, most (n=650, 56%) had a stable pattern of MacCAT-CR Understanding scores, 235 (20%) improved substantially with no evidence of decline, 273 (24%) had at least one assessment with substantial worsening. During the course of the trial, 43 (4%) fell below the initial threshold for adequate capacity, which was predicted by lower Understanding scores, more severe positive symptoms, and poorer neurocognitive functioning at baseline, and by increases in negative symptoms and deteriorating global status.

conclusionsMost participants in this long-term study had stable or improved consent-related abilities, but almost one-fourth experienced substantial worsening and 4% of participants fell below the study's capacity threshold for enrollment. Clinical investigators should monitor with special care individuals with marginal capacity or higher levels of psychotic symptoms at study entry and those who exhibit clinical worsening during a study.

Indexed as

Informed ConsentSchizophrenic PsychologyAdultAntipsychotic AgentsBiomedical ResearchCognition DisordersDecision MakingFemaleHumansLongitudinal StudiesMaleMental CompetencyMiddle AgedPredictive Value of TestsPsychiatric Status Rating ScalesSchizophreniaAntipsychotic Agents

Identifiers

PMID21561740
PMCPMC3139717

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.